These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37274474)

  • 1. Development of preoperative and postoperative machine learning models to predict the recurrence of huge hepatocellular carcinoma following surgical resection.
    Zhang Q; Fang G; Huang T; Wei G; Li H; Liu J
    Oncol Lett; 2023 Jul; 26(1):275. PubMed ID: 37274474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a machine learning model to predict early recurrence for hepatocellular carcinoma after curative resection.
    Zeng J; Zeng J; Lin K; Lin H; Wu Q; Guo P; Zhou W; Liu J
    Hepatobiliary Surg Nutr; 2022 Apr; 11(2):176-187. PubMed ID: 35464276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre- and Postoperative Models for Prediction of Recurrence in Non-B, Non-C Hepatocellular Carcinoma.
    Lin K; Huang Q; Wang L; Zeng J; Ding Z; Liu H; Fu J; Guo P; Chen Z; Zeng Y; Zhou W; Liu J
    Front Oncol; 2021; 11():612588. PubMed ID: 33680963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application value of machine learning algorithms for predicting recurrence after resection of early-stage hepatocellular carcinoma].
    Ji GW; Wang K; Xia YX; Li XC; Wang XH
    Zhonghua Wai Ke Za Zhi; 2021 Aug; 59(8):679-685. PubMed ID: 34192861
    [No Abstract]   [Full Text] [Related]  

  • 5. Survival Predictability Between the American Joint Committee on Cancer 8th Edition Staging System and the Barcelona Clinic Liver Cancer Classification in Patients with Hepatocellular Carcinoma.
    Chen LJ; Chang YJ; Chang YJ
    Oncologist; 2021 Mar; 26(3):e445-e453. PubMed ID: 32969134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Nomograms for Pre- and Postoperative Predictions of Long-Term Survival for Patients Who Underwent Liver Resection for Huge Hepatocellular Carcinoma.
    Li Y; Xia Y; Li J; Wu D; Wan X; Wang K; Wu M; Liu J; Lau WY; Shen F
    J Am Coll Surg; 2015 Nov; 221(5):962-974.e4. PubMed ID: 26382973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of prognostic dynamic nomograms for hepatitis B Virus-related hepatocellular carcinoma with microvascular invasion after curative resection.
    Bai S; Yang P; Wei Y; Wang J; Lu C; Xia Y; Si A; Zhang B; Shen F; Tan Y; Wang K
    Front Oncol; 2023; 13():1166327. PubMed ID: 37152055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nomograms for Predicting Hepatocellular Carcinoma Recurrence and Overall Postoperative Patient Survival.
    Ma L; Deng K; Zhang C; Li H; Luo Y; Yang Y; Li C; Li X; Geng Z; Xie C
    Front Oncol; 2022; 12():843589. PubMed ID: 35296018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of preoperative prognostic models including radiological features for survival of singular nodular HCC patients.
    Ding DY; Liu L; Li HL; Gan XJ; Ding WB; Gu FM; Sun DP; Li W; Pan ZY; Yuan SX; Zhou WP
    Hepatobiliary Pancreat Dis Int; 2023 Feb; 22(1):72-80. PubMed ID: 35428596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy.
    Pan YX; Chen JC; Fang AP; Wang XH; Chen JB; Wang JC; He W; Fu YZ; Xu L; Chen MS; Zhang YJ; Li QJ; Zhou ZG
    Cancer Commun (Lond); 2019 Oct; 39(1):55. PubMed ID: 31601270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nomograms Incorporating the CNLC Staging System Predict the Outcome of Hepatocellular Carcinoma After Curative Resection.
    Liao R; Wei XF; Che P; Yin KL; Liu L
    Front Oncol; 2021; 11():755920. PubMed ID: 35127471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Machine Learning-Based Model to Predict Survival After Transarterial Chemoembolization for BCLC Stage B Hepatocellular Carcinoma.
    Lin H; Zeng L; Yang J; Hu W; Zhu Y
    Front Oncol; 2021; 11():608260. PubMed ID: 33738252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating postsurgical outcomes of patients with a single hepatocellular carcinoma using gadoxetic acid-enhanced MRI: risk scoring system development and validation.
    Park SH; Kim B; Kim S; Park S; Park YH; Shin SK; Sung PS; Choi JI
    Eur Radiol; 2023 May; 33(5):3566-3579. PubMed ID: 36933020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-institutional validation of novel models for predicting the prognosis of patients with huge hepatocellular carcinoma.
    Wang XH; Liu QB; Xiang CL; Mao XH; Yang B; Li Q; Zhou QF; Li SQ; Zhou ZG; Chen MS
    Int J Cancer; 2021 Jul; 149(1):127-138. PubMed ID: 33586134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nomogram Based on Systemic Immune Inflammation Index and Prognostic Nutrition Index Predicts Recurrence of Hepatocellular Carcinoma After Surgery.
    Yang J; Bao Y; Chen W; Duan Y; Sun D
    Front Oncol; 2020; 10():551668. PubMed ID: 33163397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The study of nomogram based on Ishak inflammation score for recurrence of hepatocellular carcinoma after curative resection].
    Luo XY; Du CY; Wei XF; Jiang N; Li M; Liao R
    Zhonghua Wai Ke Za Zhi; 2018 Feb; 56(2):124-129. PubMed ID: 29397626
    [No Abstract]   [Full Text] [Related]  

  • 17. Development and validation of machine learning models for predicting prognosis and guiding individualized postoperative chemotherapy: A real-world study of distal cholangiocarcinoma.
    Wang D; Pan B; Huang JC; Chen Q; Cui SP; Lang R; Lyu SC
    Front Oncol; 2023; 13():1106029. PubMed ID: 37007095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative and postoperative nomograms for predicting early recurrence of hepatocellular carcinoma without macrovascular invasion after curative resection.
    Zhang Y; Lei X; Xu L; Lv X; Xu M; Tang H
    BMC Surg; 2022 Jun; 22(1):233. PubMed ID: 35715787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a machine learning-based model for predicting risk of early postoperative recurrence of hepatocellular carcinoma.
    Zhang YB; Yang G; Bu Y; Lei P; Zhang W; Zhang DY
    World J Gastroenterol; 2023 Nov; 29(43):5804-5817. PubMed ID: 38074914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revolutionising hepatocellular carcinoma surveillance: Harnessing contrast-enhanced ultrasound and serological indicators for postoperative early recurrence prediction.
    Tu H; Feng S; Chen L; Huang Y; Zhang J; Wu X
    Medicine (Baltimore); 2023 Sep; 102(35):e34937. PubMed ID: 37657058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.